Evidence of the milder phenotypic spectrum of c.1582G>A PIGT variant: Delineation based on seven novel Polish patients.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
11 2020
Historique:
received: 18 06 2020
revised: 21 07 2020
accepted: 23 07 2020
pubmed: 30 7 2020
medline: 21 8 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

PIGT is one of over 29 glycosylphosphatidylinositol biosynthesis defect genes. Mutations cause genetically determined disorders characterized mainly by epilepsy with fever-sensitivity, central hypotonia, psychomotor delay and congenital malformations. The disease is known as multiple congenital anomalies-hypotonia-seizures syndrome 3 (MCAHS3) or glycosylphosphatidylinositol biosynthesis defect-7. Twenty-eight cases have been reported until today. We present seven novel Polish patients, all harboring 1582G>A variant in a homozygous or compound heterozygous state which seems to cause a milder phenotype of the disease.

Identifiants

pubmed: 32725661
doi: 10.1111/cge.13822
doi:

Substances chimiques

Glycosylphosphatidylinositols 0
Acyltransferases EC 2.3.-
COOH-terminal signal transamidase EC 2.3.2.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-476

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Knaus A, Pantel JT, Pendziwiat M, et al. Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis. Genome Med. 2018;10(1):3.
Bellai-Dussault K, Nguyen TTM, Baratang NV, Jimenez-Cruz DA, Campeau PM. Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders. Clin Genet. 2019;95(1):112-121.
Mabry CC, Bautista A, Kirk RF, Dubilier LD, Braunstein H, Koepke JA. Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits. J Pediatr. 1970;77:74-85.
Thompson MD, Knaus AA, Barshop BA, et al. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: molecular genetics of the prototypical inherited GPI disorder. Eur J Med Genet. 2020;63(4):103822.
Kvarnung M, Nilsson D, Lindstrand A, et al. A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet. 2013;50(8):521-528.
Bayat A, Knaus A, Juul AW, et al. PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics. Genet Med. 2019;21(10):2216-2223.
Jiao X, Xue J, Gong P, et al. Analyzing clinical and genetic characteristics of a cohort with multiple congenital anomalies-hypotonia seizures syndrome (MCAHS). Orphanet J Rare Dis. 2020;15(1):78.
Brunet O, Lézine I, Josse D. Brunet-Lézine révisé: échelle de développement psychomoteur de la première enfance: BLR. Psy Ed Appl. 1997.
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069-1077.
Hong Y, Ohishi K, Kang JY, et al. Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins. Mol Biol Cell. 2003;14(5):1780-1789.
Nakashima M, Kashii H, Murakami Y, et al. Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3. Neurogenetics. 2014;15(3):193-200.
Pagnamenta AT, Murakami Y, Taylor JM, et al. Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders. Eur J Hum Genet. 2017;22:1-11.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521.
Cross JH. Fever and fever-related epilepsies. Epilepsia. 2012;53(4):3-8.
Jian X, Boerwinkle E, Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42(22):534-544.
Dong C, Wei P, Jian X, et al. Comparison and integration of deleteriousness prediction methods for non-synonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24(8):2125-2137.

Auteurs

Aleksandra Jezela-Stanek (A)

Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

Elżbieta Szczepanik (E)

Clinic of Pediatric Neurology, Institute of Mother and Child, Warsaw, Poland.

Hanna Mierzewska (H)

Clinic of Pediatric Neurology, Institute of Mother and Child, Warsaw, Poland.

Małgorzata Rydzanicz (M)

Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.

Karolina Rutkowska (K)

Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.

Alexej Knaus (A)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Robert Śmigiel (R)

Department of Pediatrics, Division Pediatric Propedeutics and Rare Disorders, Wroclaw Medical University, Wroclaw, Poland.

Iwona Stępniak (I)

Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland.

Michał G Markiewicz (MG)

First Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.

Snir Boniel (S)

Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.

Peter Krawitz (P)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Rafał Płoski (R)

Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH